Advisor Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $313K | Sell |
5,579
-925
| -14% | -$51.9K | ﹤0.01% | 2024 |
|
|
2019
Q3 | $307K | Sell |
6,504
-2,656
| -29% | -$125K | ﹤0.01% | 1990 |
|
|
2019
Q2 | $491K | Sell |
9,160
-2,995
| -25% | -$161K | ﹤0.01% | 1625 |
|
|
2019
Q1 | $670K | Buy |
12,155
+2,107
| +21% | +$116K | 0.01% | 1383 |
|
|
2018
Q4 | $473K | Buy |
10,048
+3,034
| +43% | +$143K | ﹤0.01% | 1442 |
|
|
2018
Q3 | $418K | Buy |
7,014
+1,455
| +26% | +$86.7K | ﹤0.01% | 1598 |
|
|
2018
Q2 | $304K | Buy |
5,559
+227
| +4% | +$12.4K | ﹤0.01% | 1675 |
|
|
2018
Q1 | $262K | Sell |
5,332
-1,264
| -19% | -$62.1K | ﹤0.01% | 1783 |
|
|
2017
Q4 | $311K | Sell |
6,596
-2,754
| -29% | -$130K | ﹤0.01% | 1670 |
|
|
2017
Q3 | $468K | Sell |
9,350
-1,565
| -14% | -$78.3K | 0.01% | 1248 |
|
|
2017
Q2 | $498K | Buy |
10,915
+56
| +0.5% | +$2.56K | 0.01% | 1146 |
|
|
2017
Q1 | $459K | Sell |
10,859
-757
| -7% | -$32K | 0.01% | 1130 |
|
|
2016
Q4 | $451K | Sell |
11,616
-1,837
| -14% | -$71.3K | 0.01% | 1074 |
|
|
2016
Q3 | $564K | Sell |
13,453
-2,584
| -16% | -$108K | 0.01% | 912 |
|
|
2016
Q2 | $590K | Buy |
+16,037
| New | +$590K | 0.02% | 834 |
|